VoL79,No.
2, 1977
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ANTIGEN OF "SERUM SICKNESS" TYPE OF HETEROPHILE ANTIBODIES IN HUMAN SERA:
IDENTIFICATION
AS GANGLIOSIDES
WITH N-GLYCOLYLNEURAMINIC ACID H. Higashi Department
and
of Biochemistry, Hokkaido University,
Naiki*
M.
Faculty of Veterinary Sapporo 060 Japan
Medicine,
and S. Matuo Department of Laboratory University, School
September
and K. 6kouchi
Services, of Medicine,
The Hospital of Kyushu Fukuoka 812, Japan
26,1977
SUMMARY: Antigen of "serum-sickness" type of heterophile antibodies in pathologic human sera was purified from equine and bovine erythrocyte stroma. The chemical nature of this antigen was glycosphingolipids with N-glycolylneuraminic acid. The antigen of equine erythrocytes was identified as hematoside with N-glycolylneuraminic acid, GlNeu(a,2-3)Gal(B,l-4)Glc(a,l-1) ceramide and the antigen of bovine erythrocytes was N-glycolylneuraminylparagloboside, G1Neu(~,2-3)Ga1(~,1-4)GlcNAc(B,1-3)Gal(~,l-4)Glc(~,l-l) ceramide. The results indicate that “serum-sickness" antibodies react with a common disaccharide moiety of non-reducing end of the both glycosphingolipids.
The production by receiving described
therapeutic
kinds
erythrocytes
of heterophile
mononucleosis and sera
in sera of patients
of
serum was first
foreign (2).
Thereafter,
these
as "serum-sickness
antibodies"
or
The antibodies
differ
antibodies,
(3) and Paul-Bunnell
infectious
antibodies
(1) and Deicher
have been called
"H-D antibodies".
bodies
injection
by Hanganutziu
antibodies
other
of heterophile
in specificity
such as Forssman anti-
antibodies, (4).
"P-B antibodies"
These antibodies
from various
from
animal
species
react
of with
(horse,
sheep,
* Correspondence
should be sent to Dr. M. Naiki. GSL, glycosphingolipid; Gal, D-galactose; Glc, D-glucose; GalNAc, N-acetyl-D-galactosamine; GlcNAc, N-acetyl-D-glucosamine; AcNeu, N-acetylneuraminic acid; GlNeu, N-glycolylneuraminic acid; Cer (ceramide), N-acylsphingosine; PBS, 0.01 M phosphate buffer (pH 7.0) containing 0.15 NaCl. Abbreviations:
Copyright AI1 rights
0 1977 by Academic Press, Inc. of reproduction in any form reserved.
M
388 ISSN
0006-291X
BIOCHEMICAL
Vol. 79, No. 2, 1977
ox and rabbit) kidney
and are
homogenate.
sera
from
goat
anti-human
patients of
properties
of all
almost
from
being
We now present
with
nature
this
N-glycolylneuraminic
been
antigen
r-globulin
of
still
extractable
75% of ethanol
and equine of
kinds
of guinea-pig were detected
(5) and also
has not
the
sediment
recieved
different
heat-stable, in
the
"H-D antibodies"
serum
"H-D antigen"
erythrocytes
with
patients
thymocyte
and precipitable
the
absorbed
Recently,
suffering
nature
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
in
fraction sera
(6).
unknown,
except
hot
solution
(6).
purification
of
"H-D antigen"
erythrocytes
and demonstrate
is
really
from
diseases
with
glycosphingolipid
in of some The some
ethanol
from first
(7)
bovine that
(GSL)
acid. MATERIAL AND METHODS
The preparation of the standard GSLs used in the experiments were described previously (8-11). The isolation of hematoside with N-glycolylneuraminic acid (GlNeu-hematoside) from equine erythrocyte stroma and N-glycolylneuraminylparagloboside (GlNeu-sialosylparagloboside) from bovine erythrocyte stroma was performed as follows. Total lipids were extracted from acetone powder of erythrocyte stroma with chloroform-methanol (2:1, v/v), and acetylated with pyridine-acetic anhydride (2:1, v/v) at 60°C. The acetylated GSLs were isolated by Florisil column chromatography according to After deacetylation, GlNeu-hematoside of equine Saito and Hakomori (12). erythrocytes was purified by silicic acid column chromatography described previously (8) and GSLs with sialic acid (gangliosides) from bovine erythrocytes were obtained by DEAE-Sephadex column chromatography following Ledeen With regard to bovine gangliosides, after reacetylation, each et al. (13). ganglioside was isolated from each other by a preparative thin-layer chromatography (TLC) on precoated silica gel plates (E. Merck Laboratories, Inc.) developed one time with a solvent system of chloroform-methanol-water (95:5: 0.5, v/v). The gangliosides were eluted from silica gel, deacetylated, neutralized, determined in the hexose content by phenol-sulfuric acid reaction and suspended in PBS containing 0.5 mg/ml sodium taurocholate (Nutritional Biochemical Corp.) for immunological tests according to the previous paper (11). The analytical TLC on a precoated silica gel plate was carried out with twice development of chloroform-methanol-2.5 M ammonia (60:40:9, v/v) and visualized by spraying with resorcinol reagent. The carbohydrate compositions of "H-D antigen"-active GSLs were analyzed by gas-liquid chromatography (GLC) as previously described (14) for determining the molar ratio of each carbohydrates and sphingosine bases and as described in Ledeen's paper (15) for sialic acid composition. Sera from thirteen different patients with different diseases were detected to have "serum-sickness" type of antibodies by determining higher calf, sheep and rabbit erythrocytes and by levels of hemagglutinin to horse, testing complete absorption of the hemagglutinin with guinea-pig kidney sediment. One of thirteen sera was obtained from a patient "J. S." who had
389
Vol.79,
BIOCHEMICAL
No. 2, 1977
AND BIOPHYSICALRESEARCH
COMMUNICATIONS
received therapeutic injection of horse anti-snake venom. Parts of "H-D antibodies" were isolated from the mixed sera of two chromatography described in Marcus's patients "C. S. and T. H." by affinity Five ml of "H-D serum" was absorbed at cold room with 10 ml of paper (16). 7.5% polyacrylamide-2.5% bisacrylamide gel containing 10 mg of equine GlNeu= hematoside, 10 mg of egg lecithin and 100 mg of cholesterol. The bound protein was recovered by elution with 3 M KSCN, dialysis against PBS and concentration to approximately 200 ug/ml. The protein solution was diffused in 1% agarose gel with rabbit antisera to different human immunoglobulin chains, r-chain, p-chain, a-chain, K-chain and r-chain (Behring Inst.) and normal rabbit serum. Sera from four different patients with infectious mononucleosis which contain high levels of "P-B antibodies" were kindly donated from Dr. Kano (School of Medicine, State University of New York) and were tested for cross-reactivity of "H-D antigen"-active gangliosides by Dr. Matuhashi (Institute for Medical Science, University of Tokyo). Hemagglutination inhibition was performed as follows. Prior to experi2 units of hemagglutinin ment, 0.2 ml of diluted H-D serum "J. S." containing was mixed with 0.2 ml of each inhibitor solution and kept for 12 hours at 4°C before 0.2 ml of 0.2% suspension of equine erythrocytes was added to. After one hour incubation again at cold room, each tube was centrifuged at 2,000 rpm for 2 min. Hemagglutination was read by gently shaking.
RESULTS Glycolipid neutral
fraction
glycolipids
Then,
and applied
different order
"H-D antigen"
fraction.
reacetylated
fractions
for
was fraction concentration
0.9 pg/ml
the most abundant
glycolipid
erythrocytes
slower
than
and sphingosines respectively. movility
detected
in only
fraction
were isolated reactivity
in equine
was Seven
as shown in Fig.
after
at the molar The GLC analysis
of TLC were identical
at the
The compound was
erythrocytes
AcNeu-sialosylparagloboside
acid,
deacetylation.
hemagglutination
content.
of bovine
TLC.
and moved from human
The compound was detected glucosamine,
ratio
of
390
galactose,
to
glucose
0.8:1.0:2.0:1.0:1.0,
of carbohydrate with
1
erythrocyte-hemagglutination
as hexose
in analytical
have N-glycolylneuraminic
column
TLC plates.
The compound D inhibited
of
slightly
was
the ganglioside
Rf values
inhibitor
D.
activity
into
were named A, B, C, D, E, F and G in
immunological
The most potent
was isolated
by DEAE-Sephadex
on preparative
those
of decreasing
and tested
erythrocytes
and gangliosides
chromatography. ganglioside
of bovine
the major
composition ganglioside
and of
BIOCHEMICAL
Vol. 79, No. 2, 1977
Fig.
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
1 TLC of each acetylated ganglioside of bovine erythrocytes. Total gangliosides (T) were separated into seven different fractions (A to G) by preparative TLC. An analytical TLC was carried out by developing with chloroform-methanol-water (95:5:0.5, v/v) and visualizing with resorcinol reagent.
bovine
erythrocytes
Wiegandt
et --
Fraction
A and C, also
ration
al.
which (171,
that
of equine
and sugar
components
is
hemagglutination
erythrocyte
(18)
by GLC analysis.
too
composition.
The other
by analytical
TLC and gave no inhibition
rig/ml.
identical
small
Fraction
sylparagloboside,
fractions
fraction but
fractions
However,
the fraction
did not
line line,
in carbohydrate only
one band
and AcNeu-sialo-
inhibitors, with
fraction
"H-D serum" and
in agarose-gel
show precipitin
391
C
by GLC to have the
The potent
precipitin
GlNeu=
at the concentration
of AcNeu-hematoside
respectively.
concent-
on TLC analysis
seemed to given
C gave a weak precipitin
the other
in movility
B and E were analyzed
D and A each gave a clear
with
in amount to be analyzed
sugar composition
by
at the
The compound A was identical
was recovered
15.0
established
GlNeu-sialosylparagloboside.
inhibited
of 1.9 yg/ml.
hematoside
had been already
reaction.
diffusion,
of
GalNAc Ga1(~,1-4)GlcNAc(8,1-3)Gal
Paragloboside
at
ganglioside
' Negative
GDla
a concentration
of
125 ug/ml
Gal(~,l-3)GalNAc(B,l-4)Gal(B,l-4~Glc-Cer I (a,2-3) AcNeu Gal(~,1-3)GalNAc(a,l-4)Gal(B,l-4~Glc-Cer 1 (a,2-3) AcNeU ' Weak
inhibition
i3,1-4)Glc-Cer Aa;i;z-3 1
( 8,1-4)Glc-Cer
GM1 ganglioside
GM2 ganglioside
GlNeusialosylparagloboside
( B,l-4)Glc-Cer
8,1-4)Glc-Cer
Gal(B,l-4)GlcNAc(B,l-3)Gal 1 (a,2-3) AcNeu Gal(B,l-4)GlcNAc(B,l-3)Gal I (a,2-3) GlNeu GalNAc(B,l-4)Gal
GlNeu(a,2-3)Gal
GlNeu-hematoside
i3,1-4)Glc-Cer
!3,1-4)Glc-Cer
AcNeusialosylparagloboside
AcNeu(a,2-3)Gal
AcNeu-hematoside
I (a,l-3)
by different
Gal(B,l-4)Glc-Cer
GalNAc(!3,1-3)Gal(a,l-4)Gal(B,1-4)Glc-Cer
structures
inhibition
Forssman
Chemical
Hemagglutination
GalNAc(~,1-3)Gal(a,l-4)Gal(B,l-4)Glc-Cer
1.
Globoside
Lactosylceramide
Glycolipids
Table
2.0
2.0
125'
-1
1252
Lowest cont. that complete inhibition
glycosphingolipids give @g/ml)
BIOCHEMICAL
Vol. 79, No. 2, 1977
Fig.
2 Double diffusion test of "H-D serum" and "P-B sera" with equine 1 to 4, GlNeu-hematoside and bovine GlNeu-sialosylparagloboside. Sera from four different patients with infectious mononucleosis; HD, Sera from a patient "Z. M." containing "H-D antibodies"; G, GlNeu= sialosylparagloboside from bovine erythrocytes (250 ug/ml); H, GlNeu= hematoside from equine erythrocytes (250 ug/ml).
GlNeu-hematoside stroma
as the only
was also
galactose,
glucose
0.9:1.0:0.9,
other
and sphingosines
of bovine
compounds used,
test
at the concentration
and GlNeu-sialosylparagloboside,
precipitin
line
The other Four
The other
GlNeu-hematoside twelve
of
all
in Table except
Only
GlNeu=
each gave a clear
fused
and the
as shown in Fig.
1 gave no precipitin
gave positive
393
The
gave weak
reacted
nor GlNeu-sialosylparagloboside
"H-D sera",
1.
125 ug/ml
employed.
"P-B antibodies"
sera containing
1.0:
strongest
"H-D antibodies"
seemed completely
compounds shown in Table
different
neither
serum containing
of
were given
and AcNeu-hematoside
hematoside
lines
ratio
as GlNeu-sialosyl-
of which
at the maximum concentration
precipitin
acid,
as shown in Table
inhibition
both
The compound
as well
structures
lactosylceramide
with
substance.
at the molar
erythrocyte the
1, gave no inhibition only
erythrocyte
The compound was the
in hemagglutination
paragloboside
from equine
GSL and had N-glycolylneuraminic
respectively.
inhibitor
purified
"H-D antigen"-active
was the most abundant
that
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
reaction
2.
reaction. with (Fig. with
2).
BIOCHEMICAL
Vol. 79, No. 2, 1977
GlNeu-hematoside proteins
in gel
of the
demonstrated
sera
diffusion
(Q-G),
K-chain
precipitin
isolated
with
The GlNeu-hematoside-binding
by affinity
chain)
(IgM)
by positive
were reaction
to human immunoglobulin and A-chain
was obtained
p-chain
chromatography
immunoglobulins
antisera
(Light
reaction
globulin
diffusion.
to be really
in gel
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
with
and a-chain
(Light
r-chain
chain).
antisera
But no
to human immuno-
(IgA).
DISCUSSION As above mentioned, different
the chemical
"H-D antigen"
communication.
active
that
terminal
disaccharide
animals,
equine,
mouse, hamster lylneuraminic
bovine,
acid
glycoproteins,
of
membrane,
erythrocyte
some of these
been detected
if
site
invade
tion
of microorganisms,
abnormal
into
some substances
intestinal
antibody"
production
is
problem
future
pathologic preparation stroma
absorption
shall
of milk
species
investigators
animals
394
still
activity have never
and many organs such an antigen antisera,
infec-
and meats from scurf, However,
can be elevated
mononucleosis of
fluids
stimulated.
why such antibodies
of infectious
In addition,
of animal
be readily
Other
carbohydrates
acid
foreign
or inhalation
sites,
human sera.
of various
of
of
cat,
"H-D antigen"
containing
human by injection
species
have N-glyco-
secretions.
from body
the
and gangliosides
N-glycolylneuraminic
in any substances
with
dog,
chicken,
compounds are known to have
Therefore,
(20) -
elk,
immunoglobulins serum and/or
But in human being,
react
20) in complex
(19,
in this
Various
pig,
monkey except
residues
such as mucin,
possibly
rabbit,
two
of the two com-
GlNeu(a,2-3)Gal.
sheep,
and ,primate
proved
moiety
"H-D antibodies" part,
of the
GSLs were first
The common disaccharide
pounds suggested
(21) -
structures
reported antigen
"H-D it
in only that
the
from erythrocyte
possessed
"H-D anti-
Vol.79,
BIOCHEMICAL
No. 2, 1977
gen" activity glycolipids
(6, both
21). did
ACKNOWLEDGMENTS: This Ministry of Education, discussion and aid for sera.
:: 3. 2: 6. 7. 8. 9. 10. 1:: 13. 14. 15. 16. 1:: 19. 20. 21.
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
But the present
"H-D antigen"
not have any "P-B antigen"
active
activity.
work was supported by a Research Grant from the We thank Dr. T. Matuhashi for valuable Japan. testing cross-reaction of H-D substances with I.
M.
REFERENCES Hanganutziu, M. (1924) Compt. Rend. SOC. Biol. 9l-, 1457-1459. Oeicher, H. (1926) Z. Ryg. Infektionskr. 106, 561-579. Forssman, T. (1911) Biochem. Z. 37, 78-115. W. W. n932) her. J. Med. Sci. 183, 90-104. Paul, J. R., and Bunnell, J. C., and August, A. (1973) Blood 42, Pirofsky, B., Ramirez-Nateos, 385-393. Kasukawa, R., Kano, K., Bloom, M. L., and Milgrom, F. (1976) Clin. EXP. Immunol. 25, 122-132. Schiff, F. (1937) J. Immunol. 2, 305-313. Naiki, M., and Taketomi, T. (1969) hap. J. EXP. Med. 39, 549-571. Naiki, M., Kamimura, H., Taketome, T., and Ichikawa, R. (1972) hap. J. Exp. Med. 42, 205-219. R. W. (1974) J. Immunol. 113, 84-93. Naiki, M., Marcus, D. M., and Ledeen, 14, 4837-4841. Naiki, M., and Marcus, D. M. (1975) Biochemistry S. (1971) J. Lipid Res. 11, 257-259. Saito, T., and Hakomori, Ledeen, R. W., Yu, R. K., and Eng, L. F. (1973) J. Neurochem. 21, 829-839. Naiki, M., Fong, J., Ledeen, R., and Marcus, D. M. (1975) Biochemistry 14, 4831-4836. Yu, R. K., and Ledeen, R. W. (1970) J. Lipid Res. 11, 506-516. Marcus, D. M. (1976) J. Amer. Gil Chem. SOC. 53, 233-245. Wiegandt, H., and Schulze, B. (1969) z. Naturforschg. m, 945-946. Yamakawa, T., and Suzuki, S. (1951) J. Biochem. 38, 199-212. Gottschalk, A. (1960) The Chemistry and Biology of Sialic Acid and Related Cambridge University Press. Sabstances, Gottschalk, A. (1972) Glycoproteins, their Composition, Structure and Function, B. B. A. Library vol. 5, Elsevier Publishing Company, Amsterdam= London-New York. Callahan, H. J. (1976) Int. Archs Allergy ~ppl. Immun. 51, 696-708.
395